Latham & Watkins advised Harmony Biosciences, while Paul Hastings LLP advised J.P. Morgan as the sole book-running manager in the offering. Harmony Biosciences Holdings, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represents UL Solutions and UL Standards & Engagement, and Weil advised Goldman Sachs, J.P. Morgan and another leading financial institution, as lead...
You must be a Standard 1 Year member to access this content.
Milbank advised Viking Holdings Ltd on the offering, Latham & Watkins advised the underwriters and Ropes & Gray advised the selling shareholders. Viking Holdings Ltd (NYSE:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented UL Solutions, and Weil advised the underwriters in the offering. UL Solutions Inc., a global leader in applied safety science based in...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represents Vistagen in the offering. Vistagen Therapeutics, Inc. (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises on Mercer International offering. Mercer International Inc. (Nasdaq: MERC), a global forest products company with operations in Germany, the United States, and...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell advised CNH Industrial Capital, and Latham & Watkins advised the underwriters. CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announced that its wholly...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins LLP and Clifford Chance advised Decarbonization Plus Acquisition Corporation II on the business combination with Tritium Holdings Pty Ltd, represented by Corrs Chambers...
You must be a Standard 1 Year member to access this content.
